Skip to content

Effects of Dry Needling on Stiffness in Latent Trigger Points

Effects of Dry Needling on Stiffness in Latent Myofascial Trigger Points: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04394741
Enrollment
51
Registered
2020-05-19
Start date
2020-06-01
Completion date
2020-08-31
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger Points

Keywords

Pain, Latent trigger point, Stiffness, Dry Needling

Brief summary

The purpose of this study is to determine whether application of Dry Needling (DN) is effective for reduced on Stiffness in Latent trigger point (LTrP) of upper trapezius. The secondary purposes are to determine the correlation on two elastography for stiffness measure (Shear-wave elastography and Strain elastography). Randomized controlled trial, in parallel with cross-control design. Two groups with LTrP in upper trapezius, and will be randomly selected to DN group or Sham-Dn group.

Interventions

Deep Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle. 1 session in upper trapezius muscle moving the needle up and down ten times.

Sham Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle with non-penetrating needles 1 session in upper trapezius muscle moving the needle up and down ten times.

Sponsors

University of Castilla-La Mancha
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 30 years * The presence of LTrP in the middle third of the upper trapezius muscle on the dominant side * Being able to provide written informed consent * Being able to follow instructions and realize clinical tests

Exclusion criteria

* Any pharmacological therapeutic * Any medical treatment or physical therapies at cervical region during the 6-month before this study - Any diagnosed health problem * Any history of head and upper extremity surgery or trauma * Any red flags to DN, (ie: metabolic diseases, pregnancy, kinesiophobia, Infection, cancer) * Absence of recurrent history of neck pain * No neck pain symptomatology the previous 6 months * Cervical disk herniation

Design outcomes

Primary

MeasureTime frameDescription
Change on Stiffness (Shear wave elastography and Strain Elastography)Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatmentShear-wave Elastography (SWE) as assessed using an Logiq S8 US system (GE Healthcare). The stiffness was determined with measuring velocity of shear waves in trapezius muscle on SWE exam. Strain elastography (SEL) as assessed using an Logiq S8 US system (GE Healthcare). The stiffness was determined by applying light repetitive compression with the hand-held transducer

Secondary

MeasureTime frameDescription
Change in Pain Pressure Threshold (PPT)Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatmentPressure-Pain Threshold as assessed by an manual mechanical algometer. PPT is the minimal amount of pressure that produces pain and is used to assess abnormalities in nociceptive processing or hyperalgesia.
Change in Thickness of muscleBaseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatmentThe muscle was scanned in the longitudinal and axial planes, taking care to avoid anisotropy. B-Mode gray scale was employed to measure muscle thickness
Change in Post-needling sorenessBaseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatmentThe procedure performed was the subject had to characterize the level of pain using a visual analog scale (VAS), ranging from 0mm (no pain) to 10mm (worst imaginable pain)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026